Information Journal Paper
APA:
CopyALEXOPOULOU, A., & DOURAKIS, S.P.. (2005). GENETIC HETEROGENEITY OF HEPATITIS VIRUS AND ITS CLINICAL SIGNIFICANCE. CURRENT DRUG TARGETS - INFLAMMATION AND ALLERGY, 4(1), 47-55. SID. https://sid.ir/paper/562950/en
Vancouver:
CopyALEXOPOULOU A., DOURAKIS S.P.. GENETIC HETEROGENEITY OF HEPATITIS VIRUS AND ITS CLINICAL SIGNIFICANCE. CURRENT DRUG TARGETS - INFLAMMATION AND ALLERGY[Internet]. 2005;4(1):47-55. Available from: https://sid.ir/paper/562950/en
IEEE:
CopyA. ALEXOPOULOU, and S.P. DOURAKIS, “GENETIC HETEROGENEITY OF HEPATITIS VIRUS AND ITS CLINICAL SIGNIFICANCE,” CURRENT DRUG TARGETS - INFLAMMATION AND ALLERGY, vol. 4, no. 1, pp. 47–55, 2005, [Online]. Available: https://sid.ir/paper/562950/en